Main Menu
News Archives
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
ArticlesActionsViewsDate
Analyst Rating: Synthes: Credit Suisse reiterates BUY rating and target price of CHF 155Printer Friendly Page Send this Story to a Friend802008/7/30 11:20
Analyst Rating: Syngenta: Credit Suisse raises to BUYPrinter Friendly Page Send this Story to a Friend492008/7/28 7:03
Analyst Rating: Logitech: Credit Suisse reduces target price to CHF 32.00 and confirms HOLD ratingPrinter Friendly Page Send this Story to a Friend612008/7/28 6:50
Company: ABB Q2 net income up 34% on strong top-line growth Printer Friendly Page Send this Story to a Friend422008/7/24 8:08
Company: Credit Suisse Group reports net income of CHF 1.2 billion in the second quarter of 2008Printer Friendly Page Send this Story to a Friend412008/7/24 7:55
Company: Syngenta Half Year Results 2008Printer Friendly Page Send this Story to a Friend382008/7/24 7:53
Analyst Rating: Lonza: Credit Suisse confirms BUYPrinter Friendly Page Send this Story to a Friend382008/7/23 9:49
Analyst Rating: ABB: Bordier code PLUSPrinter Friendly Page Send this Story to a Friend412008/7/23 9:47
Analyst Rating: Julius Bär: Credit Suisse upgrades to BuyPrinter Friendly Page Send this Story to a Friend402008/7/23 9:42
Analyst Rating: Swiss Life: Credit Suisse lowers target price, maintains HOLD recommendationPrinter Friendly Page Send this Story to a Friend762008/7/21 14:44
Analyst Rating: Baloise: Credit Suisse reduces price target, maintains HOLDPrinter Friendly Page Send this Story to a Friend382008/7/21 14:42
Analyst Rating: Roche - Bordier remains positivePrinter Friendly Page Send this Story to a Friend372008/7/21 12:03
Company: Roche first-half resultsPrinter Friendly Page Send this Story to a Friend532008/7/21 6:58
Company: Roche makes offer to acquire all outstanding shares of Genentech for US$89.00 per share in cashPrinter Friendly Page Send this Story to a Friend342008/7/21 6:55
Company: Novartis first half resultsPrinter Friendly Page Send this Story to a Friend302008/7/21 6:53
There are 15 article(s) in total
Search


Advanced Search
Investment Links